We propose that the action of KDM4D through the demethylation of H3K9 is critical in maintaining a stable epigenetic landscape of the AgRP promoter, and may offer a target to develop new treatments for obesity. Here, AGRP is linked to obesity due to melanocortin 4 receptor deficiency.